Implantación percutánea transeptal de válvula protésica aórtica sobre bioprótesis mitral degenerada
Author
dc.contributor.author
Armijo, Germán
Author
dc.contributor.author
Puentes, Ángel
Author
dc.contributor.author
Ceballos, Alejandro
Author
dc.contributor.author
Quezada, Mauricio
Author
dc.contributor.author
Tamayo, Carlos
Author
dc.contributor.author
Donoso, Hernán
Author
dc.contributor.author
Ramírez, Pablo
Author
dc.contributor.author
Backhouse, Christian
Author
dc.contributor.author
Nombela Franco, Luis
Admission date
dc.date.accessioned
2021-09-22T16:13:29Z
Available date
dc.date.available
2021-09-22T16:13:29Z
Publication date
dc.date.issued
2021
Cita de ítem
dc.identifier.citation
Revista Médica Chile 2021; 149: 137-141
es_ES
Identifier
dc.identifier.issn
0034-9887
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/182057
Abstract
dc.description.abstract
Reintervention of a mitral degenerated bioprosthesis has a high surgical risk,
especially in elderly patients with multiple comorbidities. We report a 74 years
old female with two previous cardiac surgical procedures and a new structural
mitral bioprosthesis deterioration with severe mitral regurgitation. Considering
her high-surgical risk, a fully percutaneous treatment was performed with a
balloon-expandable aortic valve in mitral position (valve-in-valve) through a
transseptal approach with a favorable outcome. This technique is an attractive
and effective option with a relatively low rate of complications that could solve
this challenging and complex disease.